Waldron Private Wealth LLC Acquires 538 Shares of DowDuPont Inc (NYSE:DWDP)

Share on StockTwits

Waldron Private Wealth LLC boosted its holdings in DowDuPont Inc (NYSE:DWDP) by 4.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,127 shares of the company’s stock after purchasing an additional 538 shares during the quarter. Waldron Private Wealth LLC’s holdings in DowDuPont were worth $699,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. PRW Wealth Management LLC purchased a new stake in shares of DowDuPont during the fourth quarter valued at approximately $26,000. Capital Financial Planning LLC purchased a new stake in shares of DowDuPont during the fourth quarter valued at approximately $36,000. Covenant Multifamily Offices LLC purchased a new stake in shares of DowDuPont during the first quarter valued at approximately $40,000. Clarfeld Financial Advisors LLC purchased a new stake in shares of DowDuPont during the fourth quarter valued at approximately $43,000. Finally, Pacific Center for Financial Services grew its holdings in shares of DowDuPont by 133.3% during the fourth quarter. Pacific Center for Financial Services now owns 952 shares of the company’s stock valued at $51,000 after buying an additional 544 shares during the last quarter. Institutional investors and hedge funds own 67.74% of the company’s stock.

DWDP stock traded up $1.37 on Friday, hitting $74.83. The company had a trading volume of 3,624,733 shares, compared to its average volume of 15,635,282. DowDuPont Inc has a 12-month low of $30.06 and a 12-month high of $48.34. The company has a current ratio of 1.72, a quick ratio of 1.14 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $168.10 billion, a P/E ratio of 18.21, a P/E/G ratio of 1.43 and a beta of 1.41.

DowDuPont (NYSE:DWDP) last issued its earnings results on Thursday, May 2nd. The company reported $2.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.10 by $0.42. DowDuPont had a net margin of 3.88% and a return on equity of 9.05%. The company had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.47 billion. During the same quarter last year, the company posted $3.36 earnings per share. The firm’s quarterly revenue was down 8.7% on a year-over-year basis. As a group, equities analysts predict that DowDuPont Inc will post 2.14 earnings per share for the current year.

A number of equities research analysts have recently commented on the stock. BMO Capital Markets increased their price target on shares of DowDuPont from $198.00 to $201.00 and gave the company an “outperform” rating in a report on Tuesday, February 26th. Barclays cut their price target on shares of DowDuPont from $174.00 to $111.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 7th. Morgan Stanley cut their price target on shares of DowDuPont from $210.00 to $129.00 and set an “overweight” rating on the stock in a report on Tuesday, April 2nd. Royal Bank of Canada cut shares of DowDuPont from a “top pick” rating to a “sector perform” rating and cut their price target for the company from $183.00 to $120.00 in a report on Tuesday, April 16th. Finally, Bank of America reiterated a “neutral” rating and set a $120.00 price target (down previously from $132.00) on shares of DowDuPont in a report on Friday, May 3rd. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $165.45.

ILLEGAL ACTIVITY WARNING: This article was first published by Zolmax and is the sole property of of Zolmax. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://zolmax.com/investing/waldron-private-wealth-llc-acquires-538-shares-of-dowdupont-inc-nysedwdp/3114296.html.

About DowDuPont

DowDuPont Inc, through its subsidiaries, engages in agriculture, materials science, and specialty products businesses in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Agriculture segment produces, and sells hybrid corn seed and soybean seed varieties; sunflowers, wheat, alfalfa, canola, cotton, rice, and sorghum; silage inoculants; and crop protection products that include weed control, disease control, and insect control.

Read More: Why are gap-down stocks important?

Want to see what other hedge funds are holding DWDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DowDuPont Inc (NYSE:DWDP).

Institutional Ownership by Quarter for DowDuPont (NYSE:DWDP)

Receive News & Ratings for DowDuPont Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DowDuPont and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Synergy Resources Corporation  Expected to Announce Quarterly Sales of $194.53 Million
Synergy Resources Corporation Expected to Announce Quarterly Sales of $194.53 Million
Jumia Technologies AG –  Expected to Announce Quarterly Sales of $39.19 Million
Jumia Technologies AG – Expected to Announce Quarterly Sales of $39.19 Million
Zacks: Brokerages Expect Encore Capital Group, Inc.  Will Announce Quarterly Sales of $356.84 Million
Zacks: Brokerages Expect Encore Capital Group, Inc. Will Announce Quarterly Sales of $356.84 Million
Zacks: Brokerages Expect Ferro Co.  Will Announce Quarterly Sales of $425.53 Million
Zacks: Brokerages Expect Ferro Co. Will Announce Quarterly Sales of $425.53 Million
Global Medical REIT Inc  Expected to Post Quarterly Sales of $16.74 Million
Global Medical REIT Inc Expected to Post Quarterly Sales of $16.74 Million
Icon Plc  Given Consensus Rating of “Buy” by Brokerages
Icon Plc Given Consensus Rating of “Buy” by Brokerages


 
© 2006-2019 Zolmax.